Depakote
Product Images NDC 21695-359

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Depakote (NDC 21695-359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure Of Divalproex Sodium (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 01)

Chemical structure diagram of the active ingredient in Depakote, showing the molecular arrangement including carbon chains, hydroxyl groups, and sodium ions.*

FDA Label Image

Figure 1 (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 02)

A line graph showing the percentage reduction in CPS rate (y-axis) versus the percentage of patients (x-axis), comparing Depakote (solid line) and placebo (dashed line). The graph indicates improvement and worsening relative to no change, illustrating Depakote's greater reduction in CPS rate across patients compared to placebo.*

FDA Label Image

Figure 2 (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 03)

A line graph comparing high dose and low dose Depakote effects on the percentage reduction in CPS rate among patients. The x-axis shows the percentage of patients (100% to 0%), and the y-axis shows percentage reduction in CPS rate from -100% to 100%, with directions indicating improvement or worsening. Two lines, solid for high dose and dashed for low dose Depakote, illustrate differences in patient response rates.*

FDA Label Image

Figure 3 (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 04)

A bar chart comparing two groups: Placebo and Depakote ER. The Placebo bar is approximately 0.6 units, and the Depakote ER bar is elevated at approximately 1.2 units, indicating a significant difference (p=0.006) between the two groups.*

FDA Label Image

Depakote 250mg (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 05)

Label for Depakote 250 mg extended-release (ER) tablets, containing divalproex sodium equivalent to valproic acid 250 mg per tablet. The package contains 30 tablets and is labeled RX Only. The product is distributed by Physician Partner, Thousand Oaks, CA 91320, with a note to store at controlled room temperature 15-30°C (59-86°F) and keep out of reach of children. The label includes the NDC number 21695-359-30 and identifies the product ID PD035930.*

FDA Label Image

Depakote 500mg (Bfbc2cfb 8e96 4cf2 81c7 D63a1b7365c4 06)

Depakote 500mg ER Tablets packaging label from Physician Partner, showing NDC 21695-163-15 and quantity of 15 tablets. Each extended-release tablet contains divalproex sodium equivalent to 500mg valproic acid. The label includes storage instructions, batch and expiration details, and packaging by Abbott Pharmaceuticals PR Ltd, with address in California.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.